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ABSTRACT 
Eric W. Lai: Radiation-Induced Osteoporosis: A Look Into the Changes in Trabecular Bone 
After Exposure to Acute and Fractionated Ionizing Radiation Using Mice Model 
(Under the direction of Caterina Gallippi) 
 
 
 
 Radiation therapy is an important tool in the treatment of women with gynecologic 
cancers. An increased incidence of spontaneous hip fractures is observed in women after 
receiving therapeutic irradiation.  
 In this study, we explored the relationship between dosage and bone health by 
exposing sixteen-week-old C57BL6/J mice to both acute and fractionated dosages of ionizing 
radiation. The mice were divided into three groups – 18 Gy single acute dose, 3 x 6 Gy 
fractionated dose and non-irradiated controls. Bones were collected 14 days after irradiation. 
MicroCT and finite element analyses were used to characterize microarchitectural and 
structural changes in the proximal metaphysis of the tibia.  
 Trabecular volume, connectivity density and bone mineral density all declined in the 
irradiated groups. The fractionated dose group did not demonstrate different bone loss than 
the single acute dose group in a statistically significant way. Further work is required to 
elucidate the complex relationship between single acute dose and its fractionated counterpart. 
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CHAPTER 1: INTRODUCTION AND MOTIVATION 
Radiation therapy or radiotherapy is an established cancer treatment modality and is 
estimated to be used in 50%-60% of all cancer cases (Beyzadeoglu, 2010).  There are two 
major methods of delivering radiation therapy. The first method, external-beam radiation 
therapy (EBRT), uses an irradiator machine that is located outside the patient’s body. The 
second method, brachytherapy, places radioactive material inside the body near the cancer 
cells (Halperin et al., 2013). In both cases, collateral damage in healthy, noncancerous tissues 
following therapeutic irradiation is an unfortunate side-effect that immensely impacts the 
quality of life and long-term survival of cancer patients. In particular, irradiation of healthy 
bone tissues during cancer therapy can result in atrophy and increased risk of fracture at 
several skeletal sites, particularly the hip (Willey et al., 2010). In the U.S., over 300,000 
hospitalizations per year are directly caused by hip fractures. For senior citizens, hip fractures 
have a 24% mortality rate within the first year. In addition, there is a 250% increased risk of 
fracture at another site in patients suffering from hip fractures (Shuler et al., 2012).   
As more cancer patients undergo radiation therapy with increasing success in initial 
survival, it has become increasingly important to prevent and minimize long-term risk of 
bone fractures from the very treatments that are keeping the patients alive (Green and Rubin, 
2014; Hu et al., 2007). In 2017, the American Cancer Society estimated approximately 1.7 
million new cancer diagnoses in the U.S. alone, with roughly 850,000 new cases for each 
gender. Of these, cancers in the pelvic region (urinary, genital, colorectal and anal) accounted 
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for approximately 42% in men and 26% in women. Half of the new diagnoses in women, 
accounting for over 100,000 new annual cases, could be attributed to gynecological cancers 
(ACS, 2017; Siegel et al., 2017). Gynecological cancers encompass five main types of cancer 
that affect a woman’s reproductive organs: cervical, ovarian, uterine, vaginal and vulvar. The 
typical treatment plans for all five types of gynecological cancers use a combination of 
surgery, radiation and chemotherapy, with staging and tumor size as the determining factors 
(Beyzadeoglu, 2010; Halperin et al., 2013; Usmani et al., 2005). In early stages where the 
cancerous cells are localized with limited tumor sizes, invasive surgical removal is the 
primary treatment modality and is typically followed by radiation therapy to kill any 
remaining cancer cells (Morris et al., 1999). In later stages that involve significantly larger 
tumor sizes and/or metastasis of the disease, radiation combined with chemotherapy is used 
both before surgery to shrink the tumors for more effective removal, and after surgery to treat 
the remaining affected regions (Rotman et al., 2006). Risk factors for gynecological cancers 
increase with age (Halperin et al., 2013). When combined with the age-related bone loss or 
osteoporosis, radiation therapy associated with gynecological cancers puts older women who 
are pre- or post-menopausal at a particularly high risk for dangerous hip fractures (Oh et al., 
2015). For example, women treated for early stage pelvic tumors from gynecological cancers 
have exhibited a greater than 65% increased incidence of hip fracture five years after 
completing radiation therapy, causing a substantial increase in morbidity and mortality 
(Baxter et al., 2005; Willey et al., 2011). 
 One way to minimize radiotherapy’s collateral damage to healthy cells is to break up 
the total radiation dose and administer it to the patient in smaller doses spread out over time. 
This process is called fractionation. This allows time for the healthy cells to repair damages, 
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as cancerous cells have poorer rate of recovery. In addition, certain stages of the cell cycle 
may provide some radiation resistance qualities (Hall and Giaccia, 2012). Fractionation 
allows the cancerous cells that survived the initial dose from being in the less radiosensitive 
stages to progress to a different stage of the cell cycle that is more vulnerable to radiation. 
The typical radiation therapy dosage for cervical cancer ranges from 40 Gy to 70 Gy, with a 
median treatment dosage of 45 Gy (Matsuura et al., 2007; Morris et al., 1999). For adults, the 
overall dosage is usually administered in daily fractions of 1.8 Gy – 2.0 Gy. For children, the 
daily fractions are typically slightly lower at 1.5 Gy – 1.8 Gy. In the United States, a general 
rule of thumb for fractionated irradiation is dividing the total desired dosage into 30 equal 
fractions, administered five consecutive days per week over six weeks (Pollack and Ahmed, 
2011). However, there really is not one typical fractionation schedule. Treatment regimens 
can differ from one disease to another, one oncologist to another, and even one patient to 
another (Cho et al., 2005; Khalil et al., 2003).   
Overall Goal and Hypothesis 
 The work presented in this manuscript is motivated by two main reasons: the 
prevalence and importance of radiation therapy in modern cancer treatment regimen, and the 
significant increase in morbidity and mortality in cancer patients from increased fracture risk. 
The goal of this study is to develop an animal model to explore and characterize the 
differences in the effects between single acute dose versus fractionated dosage on healthy 
bone tissues. The active growth region of the tibia will be the focus, and any potential bone 
loss will be characterized and quantified in terms of structural changes, bone mineral density 
and various trabecular bone parameters obtained through micro-computed tomography or 
micro-CT. In addition, finite element analysis will be used toobtain insights into the effects 
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of microstructural changes have on overall bone strength. Our hypothesis is that ionizing 
radiation administered in fractionated dosages will have a less deleterious effect on healthy 
bone tissues compared to the equivalent dosage given in one single acute dose.      
We hope the insights obtained from this work will shed additional light on the 
intricate relationship between ionizing radiation and bone loss, ultimately leading to 
improvements in both the efficacy of gynecological cancer radiation therapy and quality of 
life for the cancer patients.  
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CHAPTER 2: BACKGROUND 
General Bone Physiology 
 In the human body, bones serve five major functions: protection of vital organs, 
structural support for the entire body, blood production in the bone marrow, vital mineral 
storage, and framework to enable movement by working with skeletal muscles, tendons and 
ligaments to allow for transfer of force. Typically, bones are classified by their shapes. This 
results in five major types of bones: long, short, flat, irregular and sesamoid (Allen and Burr, 
2014; Moore and Dalley, 2006). Long bones are subjected to the majority of the load during 
normal daily activities and therefore essential to basic skeletal mobility. For this manuscript, 
we will focus on long bones, since their load-bearing status leads to a higher risk of fracture. 
We will discuss basic bone anatomy, three types of bone cells and the bone remodeling 
cycle. 
Basic Bone Anatomy 
The two basic bone structures are cortical and trabecular bone. Cortical bone, also 
known as compact bone, is the dense hard outer shell that make up about 80% of the adult 
skeleton’s total bone mass with a porosity of 5%-10%. It provides excellent compressive 
strength and resistant to bending and torsion (Allen and Burr, 2014). The overall remodeling 
rate is about 2% - 5% per year in healthy adults. As a result, cortical bone is found in areas 
that are load-bearing or need protection, such as the vertebrae, shaft of long bones and the 
skull. 
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Trabecular bone, also known as cancellous or spongy bone, is composed of thin 
interconnected struts that make up the porous structure inside the cortical shell. These struts 
or trabeculae account for the remaining 20% of the adult total bone mass with a 50% - 90% 
porosity (Burr and Akkus, 2014; Moore and Dalley, 2006). Trabecular bone adds mechanical 
support by directing the load forces to the stronger outer cortical bone. This allows for 
deformation and helps the bone as a whole to absorb load forces more efficiently with 
minimal increase in overall bone weight (Moore and Dalley, 2006). With its larger surface 
area compared to cortical bone, trabecular bone has a higher rate of bone turnover that allows 
for structural remodeling. In response to the location and direction of loading, trabecular 
bone will optimize its number and thickness to maximize bone strength. Reduction in 
connectivity or trabecular number reduces bone stiffness by up to 300% more than reduction 
in trabecular thickness alone (Burr and Akkus, 2014). 
 
Figure 1: Basic bone anatomy 
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Bone marrow is the soft, gelatinous tissue found in the medullary cavities inside the 
cortical shell. There are two types: red and yellow. Red bone marrow contains hematopoietic 
stem cells or blood-forming stem cells. They give rise to red blood cells (erythrocytes), white 
blood cells (leukocytes) and platelets (thrombocytes). In long bones, red marrow is found 
among the trabecular bone. Yellow bone marrow contains mesenchymal stem cells, which 
give rise to fat, cartilage and bone cells. In humans, bone marrow remains red until around 
the age of 7, due to the high need of blood formation during early development. Yellow bone 
marrow gradually replaces the red marrow as the body ages beyond age 7. There is on 
average approximately 2.6 kg of bone marrow in an adult human, with a 50/50 ratio of red 
and yellow marrow (Moore and Dalley, 2006; Nichols, 2017).  
The outside and inside of the bone are covered with fibrous membranes called the 
periosteum and endosteum, respectively. These membranes, rich with capillaries, are 
responsible for nourishing the external and internal aspects of the bone (Netter, 1987). 
 
Figure 2: Periosteum and endosteum 
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Long bones, such as the femur and tibia, contain a hard outer cortical shell, a 
cancellous trabecular inner structure and a bone marrow cavity. The long shaft is called the 
diaphysis. It is composed of primarily thick cortical bone and contains the cavity for yellow 
bone marrow in human adults. The metaphysis is found at the end of the diaphysis. It 
contains red bone marrow and trabecular bone enclosed by a thin cortical shell. The 
epiphysis is the rounded head at each end of the bone. It contains trabecular bone enclosed by 
a relatively thin cortical shell. The growth plate, also known as the epiphyseal plate, is found 
between the epiphysis and metaphysis. During periods of growth, long bones grow outward 
from the growth plates. Once growth is complete, the plate closes and is replaced by solid 
bone.   
   
 
Figure 3: The anatomy of the osteon 
The microscopic unit that makes up the bulk of cortical bones is called the osteon, 
which consists of concentric lamellae organized around Haversian canals. These canals 
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provide the necessary channel for nerves and blood vessels, and appear as dark circular holes 
in bone cross sections. Canaliculi, small dots that contain osteocytes and surround the 
Haversian canal, are visible cues for lamellar boundaries. The outermost boundary of a 
lamella is the cement line, and it indicates where bone resorption has stopped. Cement lines 
function as barriers to microcrack propagation and help to maintain the osteon’s structural 
integrity on a microscale (Burr and Akkus, 2014).   
Bone Cells 
 There are three main types of bone cells: osteoblasts, osteocytes and osteoclasts. Each 
serves a distinct function and interacts with each other via various signal pathways to form 
the basis for the bone remodeling process.  
Osteoblasts 
Osteoblasts are responsible for bone formation. They achieve this through secretion 
of bone matrix protein osteocalcin and rapid production of type I collagen to form osteoid, 
which is the unmineralized precursor to the mature and fully mineralized bone tissue 
(Bellido, 2014). The osteoblast lifecycle starts with mesenchymal stem cells that develop into 
osteoprogenitor or preosteoblastic cells. Once they adhere to the bone matrix, alkaline 
phosphatase is secreted. This is followed by the expression of type I collagen and the 
secretion of the extracellular matrix. At the onset of calcification, the osteoblast cells secret 
osteocalcin, osteonectin, osteopontin, bone sialoprotein and other products (Marie, 1998). 
Once the bone matrix synthesis is complete, osteoblast cells will either undergo apoptosis or 
flatten and cover the bone surface, eventually becoming embedded in the newly formed bone 
matrix. At this point, the embedded osteoblasts become osteocytes (Bellido, 2014).     
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 Figure 4: The osteoblast lifecycle  
 Various signaling pathways and proteins regulate the osteoblast’s proliferation and 
differentiation. Wnt pathways are instrumental in signaling mesenchymal stem cells to start 
down the osteoblastic pathway. They also play a role in stimulating the differentiation of 
preosteoblasts and the inhibition of osteoblastic apoptosis. Another signaling pathway is the 
bone morphogenetic protein (BMP), which controls osteoblast differentiation, promotes bone 
matrix protein synthesis and induces cell apoptosis at the end of the cycle (Bellido, 2014; 
Marie, 1998). Mature osteoblasts produce insulin-like growth factor (IGF), fibroblast growth 
factor (FGF) and transforming growth factor beta (TGF-β) to expedite osteoblastic precursor 
cells. Prostaglandins and IGF stimulate the proliferation of osteoblasts and encourage bone 
collagen synthesis (Marie, 1998).  
Osteocytes 
 Osteocytes are mature osteoblasts that have become flattened and embedded in the 
newly formed bone matrix. They develop long dendrites that extend into the bone matrix and 
are responsible for starting the bone remodeling process in response to mechanical loading or 
microcracks. Osteocytes use their long dendrites to monitor the health of the bone matrix and 
to form a network with other osteocytes, enabling an extensive signaling and protein 
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exchange pathway. Like osteoblasts, osteocytes also secrete proteins that stimulate 
mineralization, including osteocalcin and alkaline phosphatase (Bellido, 2014). 
 The lifecycle of osteocytes consists of four stages: formative, steady-state, resorptive 
and degenerative. In the formative stage, flattened osteoblasts embed themselves into the 
newly formed bone matrix. In steady-state, the osteocyte lies dormant with very little 
metabolic activity. This is followed by the resorptive stage where the osteocyte remodels 
surrounding matrix. Finally, the osteocyte dies in the degenerative stage (Aarden et al., 
1994). 
Osteoclasts 
 The main responsibility of osteoclasts is bone resorption, or the breaking down of 
bones. They are multinucleated and use an unique bone-cell interface consisting of 
filamentous actin structures called podosomes to attach to bones (Bellido, 2014). Bone 
resorption is conducted through a H+ adenosine triphosphate mediator in an exocytosis-like 
process (Teitelbaum, 2000). Hydrolytic enzymes are secreted to acidify and break down the 
bone matrix. The degraded bone fragments are processed and discharged by the osteoclast. 
The final result of the bone resorption process is a pit called Howship’s lacunae (Bellido, 
2014).         
Bone Remodeling Cycle 
 The bone remodeling process is the sum of the activities by the osteoblast, osteocyte 
and osteoclast. It forms the foundation for the life cycle of bone tissues. There are five stages: 
activation, resorption, reversal, formation and quiescence (Allen and Burr, 2014).  
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Figure 5: The bone remodeling cycle 
 
In the activation stage, one or more dying or damaged osteocyte releases RANKL and 
various other factors to prompt osteoclast activity. Preosteoclasts follow the signal and start 
to migrate toward the damaged location in the bone. Healthy osteoctyes nearby release 
antiapoptotic signals to protect healthy bone tissues and limit resorption to only the damaged 
region (Allen and Burr, 2014).  
Resorption starts when the preosteoclasts become mature osteoclast cells. They signal 
the bone lining cells to allow for attachment to the damaged region. Once attached, 
osteoclasts secrete hydrolytic enzymes to break down the bone matrix and digest the 
degraded tissues. The result is a Howship’s lacuna (Bellido, 2014). 
In the reversal stage, macrophages signals preosteoblasts and prepare the Howship’s 
lacuna for new bone formation. When this stage is finished, mature osteoblasts begin the 
bone formation process by secreting type 1 collagen and other bone matrix proteins. 
Mineralization follows when solid calcium phosphate crystals are formed from the soluble 
12 
 
calcium and phosphate in the newly formed bone matrix. At this point, osteoblasts either 
undergo apoptosis or become flattened and embedded, eventually maturing into osteocytes 
(Allen and Burr, 2014). Finally, the bone enters the quiescence stage.  
The biomarkers associated with the bone remodeling cycle are summarized in table 1.  
 
Table 1: Common biomarkers associated with bone formation and resorption (Allen and 
Burr, 2014) 
Osteoporosis 
Osteoporosis is a disease of the bones that stems from an imbalance between the 
activities of the osteoblasts and osteoclasts, cells that are responsible for bone formation and 
resorption, respectively. In a patient with osteoporosis, the overall bone turnover rate is 
skewed toward net resorption, resulting in the loss of bone mineral density and alterations in 
the bone microstructure. These changes ultimately decrease overall bone strength and 
increase the risk for formation of fractures that otherwise would not form. Over 70 million 
people worldwide are at risk of developing osteoporotic fractures. Depending on the location, 
fractures from osteoporosis can lead to reduced mobility, disability or even early mortality 
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(Damilakis et al., 2010; NIH Consensus Development Panel on Osteoporosis Prevention, 
2000; Shuler et al., 2012). Another reason osteoporosis is dangerous is due to the fact that it 
is often detected only after a spontaneous fracture has taken place (Shuler et al., 2012).   
Although commonly associated with older females, osteoporosis occurs in both 
genders and across all ethnic groups. Conditions that promote the onset of this disease 
include the lack of estrogen in females and androgen in males, inadequate supply of calcium 
and/or vitamin D, bone cancer, thyroid diseases, insufficient load-bearing exercises and old 
age (Green and Rubin, 2014).  
The mechanism of osteoporosis involved a net imbalance in the activities of 
osteoblasts and osteoclasts, where the net resorption rate is higher than that of the formation. 
Trabecular bones are especially vulnerable to increased bone turnover and resorption (Shuler 
et al., 2012). As they thin and lose bone mass, trabecular struts eventually lose connection 
with each other and fail. This results in a decrease in connectivity density (ConnD), and 
additional loss in bone strength from more than just thinning alone. In addition, once the 
connection has been broken, it is impossible to reconnect trabecular struts (Allen and Burr, 
2014), with the resulting bone becoming weakened and more prone to suffer fractures. This 
is especially true for regions of the skeletal system with high percentage of trabecular bone, 
such as the wrist, vertebrae and hip (Allen and Burr, 2014; Damilakis et al., 2010; Shuler et 
al., 2012). Figure 6 on the following page gives a visual comparison between healthy and 
osteoporotic trabecular bones.     
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 Figure 6: Healthy and osteoporotic trabecular bones 
 The WHO Fracture Risk Assessment Tool (FRAX) and T-scores are the current 
standard tools for assessing osteoporosis. With FRAX, potential patients and their associated 
fracture risks are identified through parameters that include country of origin, age, gender, 
personal and family history involving fractures, cigarette and alcohol usage, body mass index 
(BMI), bone mineral density (BMD) and history of rheumatoid arthritis (Shuler et al., 2012). 
With the T-score, patient’s bone mineral density is compared to a young reference population 
near peak bone mass. Standard deviation values are then used to determine risk level 
(Damilakis et al., 2010).   
Ionizing Radiation 
 Radiation is defined as energized particle or waves traveling through a medium or 
space. There are two types of radiation: non-ionizing and ionizing. On one end of the 
electromagnetic spectrum, the non-ionizing radiation includes examples such as radio waves, 
heat and visible light. These types of waves are relatively low in energy and do not pose 
15 
 
harm to biological organisms. Ionizing radiation resides on the other end of the 
electromagnetic spectrum and includes ultraviolet, X-rays and Gamma rays. These types of 
radiation have much higher energy – enough to successfully knock loose a valence electron 
from the target material’s atomic structure, resulting in the creation of an ion or free radical. 
Free radicals are very chemically reactive and highly damaging to biological tissues (Hall 
and Giaccia, 2012).    
  Radiation is further classified into directly and indirectly ionizing. Direct ionizing 
radiation has a high enough kinetic energy that it is able to directly disrupt the atomic 
structure of the absorber it passes through and affects chemical and biological changes. This 
radiation is less common and includes heavy charged particles. Indirectly ionizing radiation 
has less kinetic energy and does not produce chemical and biologic damage by itself. Instead, 
when absorbed by a target, it passes its energy to produce fast-moving charged particles that 
in turn cause damage (Hall and Giaccia, 2012). Examples of indirectly ionizing radiation 
include X-rays and Gamma rays.  
Biologic effects of radiation primarily result from damage to deoxyribonucleic acid or 
DNA. There are two mechanisms ionizing radiation can cause harm to DNA. In direct action, 
the ionizing radiation creates ions that directly impact and damage the DNA structure. These 
require radiation with high linear energy transfer (LET), such as neutrons and other heavy 
charge particles. In indirect action, the ionizing radiation creates free radicals that in turn 
interact with the DNA. One of the most common free radicals is the hydroxyl radical (OH), 
produced when a water molecule loses one of its oxygen atoms. It is estimated that 2/3 of all 
damage to mammalian cells are from hydroxyl radicals (Beyzadeoglu, 2010; Hall and 
Giaccia, 2012). 
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Ionizing radiation induces multiple forms of damage to the DNA molecule. These 
include base damage, single and double strand breaks in the DNA helix, and DNA protein 
crosslinks. Double strand breaks are the most lethal form of ionizing radiation induced 
damage, and is believed to be the cause of majority of radiation-induced cell death 
(Beyzadeoglu, 2010; Hall and Giaccia, 2012). The cell has evolved complicated series of 
sensors and pathways to respond to these radiation-induced damages and attempt to initiate 
repair. However, cells go through the cell cycle as they propagate and proliferate. The stages 
of the cell cycle include the mitosis (M) phase, growth phase (G1), DNA synthesis and 
replication phase (S) and the dormant phase (G2). It is during the time of cell division that 
the cell is most sensitive to radiation and its induced damage. In terms of the cell cycle, 
mammalian cells are most radiosensitive in G2 and M phase and most resistant in late S 
phase (Hall and Giaccia, 2012). The reasons for radiosensitivity changes through the cell 
cycle are still not fully understood.  
The linear-quadratic model is currently the most widely accepted model for 
describing radiation-induced cell death. Also known as the Fowler equation, it was first 
introduced in 1972 and still remains as the foundation for relating dose to survival fraction 
(Douglas and Fowler, 1976; Fowler, 2010):  
    Surviving fraction (SF) = e-αD-βD2 
D is the radiation dosage, and α and β are experimental constants. It follows the accepted 
rationale that double strand DNA breaks are the most lethal, and this could be caused by 
either a single or double radiation track or encounter. Single track radiation encounter is 
represented by the first D and double track with D2. Cell death is thought to follow the 
Poisson distribution from cell to cell, resulting in the final form of the question.        
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Mouse Model & Strain 
 No animal model is perfect, as each carries with it its own advantages and 
disadvantages. In this study, we chose to use C57BL/6 mice in our animal model for several 
reasons. Mice have a relatively easily manipulated genome. Their skeletal system is similar 
to that of the humans. Like humans, mice suffer loss of cancellous or trabecular bone, 
thinning of the hard outer cortical bone and increased cortical porosity as they age. From 
histological evidences, both humans and mice have similar pathways for bone loss, mainly 
through lowered or inadequate osteoblast activities, which results in insufficient refilling of 
resorption cavities created by the osteoclasts during bone remodeling (Jilka, 2013).  
 The C57BL/6 strain’s age-related bone loss exhibits a remarkably close pattern of 
response compared to humans. In a longitudinal bone mineral density (BMD) study 
involving 26 inbred mouse strains, multiple strains showed noticeable variability in age-
related bone loss as determined by dual-energy X-ray absorptiometry (DXA) (Ackert-
Bicknell C; Maddatu et al., 2012). Between the age of 12 and 20 months, DBA/2 females 
showed around 4% decrease in BMD. The NZO/HILtJ strain suffered 8% decrease in BMD 
during the same period. On the other end of the spectrum, RIIIS/J females increased by 10% 
in BMD during the same period. C57BL/6 mice did not experience a significant change in 
BMD, by comparison. In addition, there were also differences in bone loss rate between 
genders in certain strains. But with C57BL/6 mice, the rate of bone loss was similar between 
16 and 30 months of age (Almeida et al., 2007). This suggests that insights obtained from 
this study may be useful in shedding light on radiation-induced osteoporosis and related 
increase in fracture risk in not only females, but also their male counterparts as well.
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CHAPTER 3: METHODS AND RESULTS 
Overall Goal and Aims  
 The overall goal of this study is to gain additional insight into the causal relationship 
between ionizing radiation and bone loss induced by it in otherwise healthy bone tissues. 
This will be achieved through the completion of the following aims: 
• Develop an animal model to explore and characterize the differences in the effects 
between single acute dose versus fractionated dosage on healthy bone tissues 
• Quantify the amount of bone loss in the spongy trabecular region of the tibia, where 
the bone growth and remodeling process is the most active 
• Examine the role of structural strength in the overall strength of the bone using 
specimen-specific models in finite element analysis  
Methods 
 This was a 14-day animal study. Thirty-six female, sixteen-week-old C57BL/6 mice 
were obtained from Charles River Laboratories International, Inc. in Morrisville, NC through 
National Institute of Aging (NIA). The mice were randomized and divided evenly into three 
study groups with twelve animals each: NR (non-irradiated control), 18 Gy single acute dose 
and 3x6 Gy fractionated dose. To monitor general health and well-being, weight for each 
mouse was measured and monitored at baseline and throughout the duration of the study. 
Mice exhibiting a 20% or larger decline from their baseline weight within the first three days 
were deemed under duress and removed from the study as part of the standard animal safety 
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protocol. The study animals were housed at the animal facility on the campus of the 
University of North Carolina at Chapel Hill. Each cage housed 5 animals. Cages were 
grouped together based on normalized weights of the mice before being assigned to one of 
the three study groups.  
The X-Rad 320 Biological Irradiator (Precision X-Ray, North Branford, CT) was 
used to deliver the desired radiation dose at 0.5 Gy/minute to the study groups. Pelvic 
irradiation started on day 0 for both the 18 Gy single acute dose and 3x6 Gy fractionate dose 
groups. The fractionated dose group received the second and third fraction at 72 hour 
intervals. During exposure, isoflurane was used to sedate the animals. A custom delivery 
piping system was created to ensure a steady and constant delivery of isoflurane into each 
mouse inside the X-Rad 320. Once sedated, mice from each cage were placed in the prone 
position inside the irradiator. The irradiator’s collimator was adjusted to only expose each 
animal from the pelvic region downward.  
 At the end of the study, the study animals were humanely euthanized via cardiac 
puncture and exsanguination followed by cervical dislocation. Right tibiae were harvested 
from all 36 animals. The bones were cleaned and fixed in formalin for 48 hours before going 
into stable storage in 70% ethanol.  
  Micro-CT analysis (µCT 80; Scanco Medical AG, Bassersdor, Switzerland) of the 
tibia was conducted in the 1 mm region of the metaphysis just below the epiphyseal plate. 
Images of each sample were obtained with a 10 µm voxel size.  Once specimen was scanned, 
the cortical and trabecular sections were manually delineated through the creation of contours 
or regions of interest. This was followed by segmentation, or the identification of bone 
material in the region of interest. A threshold value for mineralized material was used to 
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accept or reject a voxel as bone material, ideally including all visible bone while excluding 
all other artifacts. Six trabecular microarchitectural parameters were obtained for analysis: 
BV/TV (trabecular bone volume fraction), vBMD (volumetric bone mineral density), ConnD 
(connectivity density), TbTh (trabecular thickness), TbSp (trabecular separation) and TbN 
(trabecular number). 
 Finite element analysis was used to analyze the same 1 mm region. Mesh data for 
both the isolated outer cortical shell and the whole bone including the trabeculae was created 
from the raw micro-CT images using a voxel-to-element conversion. This data was then 
exported over to Abaqus (Abaqus/CAE 6.9-EF1, Dassault Systems Simulia Corp, 
Providence, RI) to create subject specific finite element models. The mesh models were then 
subjected to a basic compression test with a 0.5% downward displacement (5 µm) to simulate 
axial compression. Material properties were assumed to be isotropic or homogenous with a 
Young’s modulus of 10 GPa and a Poisson’s ratio of 0.3. Of the many variations of axial 
compression test, we chose to fix the bottom surface and displace the top, as this was 
sufficient given that the simulated loading was static in nature. To characterize bone strength, 
we looked at the stiffness, defined as the resultant force divided by the applied displacement. 
Structural efficiency, defined as stiffness divided by total bone volume, is a way to look at 
the material strength normalized to unit volume. Stiffness and structural efficiency data were 
obtained from the 0.5% axial compression tests for analysis.   
 GraphPad Prism 5.0 (GraphPad Software, San Diego, CA) was used for all statistical 
analyses. Outliers in the dataset were defined to be any data points that were at least three 
standard deviations from the mean in either direction. A one-way ANOVA was performed to 
determine the significance of the dataset, with P-values less than 0.05 considered statistically 
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significant. Tukey’s Honest Significant Difference test was then performed as the multiple 
comparison test to determine where those significant differences lie. 
Results 
Body Mass 
 The weight of each animal was measured and monitored throughout the study. There 
were no exclusions throughout the study, and the same trend was seen across all three 
groups. The mean weight for all three groups are shown below. 
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Figure 7: Average mice weight by study group. Note the similar initial drop in weight across 
all groups, including control.  
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Trabecular Microarchitectural Parameters 
Trabecular Bone Volume Fraction  
 The trabecular bone volume fraction (BV/TV) is shown below in Figure 8. Results 
were statistically significant for the 3x6 Gy fractionated group when compared to the control, 
with a 32.5% decrease in overall trabecular bone volume fraction (p-value = 0.0036). The 18 
Gy single acute dose group showed a 17.4% decrease when compared to the control, but it 
was not deemed statistically significant (p-value = 0.1594). When compared with each other, 
the two irradiated groups showed some differences, with the 3x6 Gy have on average bigger 
loss. However, this difference was not deemed statistically significant.  
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Figure 8: Trabecular bone volume fraction (BV/TV) indicates the fraction of a given volume 
of interest that is occupied by mineralized bone The fractionated group show significant bone 
loss compared to the control. Although sizable, the acute dose group’s decrease in BV/TV 
compared to the control was not deemed statistically significant. Mean +/- SEM.  
*P < 0.05  
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Volumetric Bone Mineral Density 
 Figure 9 shows the results for the volumetric bone mineral density (vBMD). This 
follows a similar trend to BV/TV, with both irradiated groups showing notable decrease 
when compared to the control. The 18 Gy group showed a decrease of 31.9% compared to 
the control (p-value = 0.0239). The 3x6 Gy fractionated group showed a 57.4% decrease 
when compared to the control (p-value < 0.0001). The differences for both the single acute 
dose and fractionated groups are deemed statistically significant. 
 Like BV/TV, there is also a noticeable difference between the 18 Gy and 3x6 Gy 
irradiated groups. Again, it was not deemed statistically significant, with a p-value of 0.0831.   
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Figure 9: Volumetric bone mineral density (vBMD) indicates the average bone mineral 
density in a given volume of interest. Both fractionated and acute dose groups showed 
statistically significant loss in vBMD compared to the control.  Mean +/- SEM. *P < 0.05 
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Connectivity Density 
 Results for connectivity density (ConnD) are shown below in Figure 10. The data  
follow the general trend as seen so far, with both irradiated groups showing decreased values 
when compared to the control. However, the differences were not deemed statistically 
significant. The 18 Gy group showed a 19.6% decrease (p-value = 0.6384), while the 3x6 Gy 
group showed a 40.5% decrease (p-value = 0.1598). The difference between the two 
irradiated groups was also not statistically significant.  
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Figure 10: Connectivity density (ConnD) measures the degree of connectivity of trabeculae 
normalized by total volume. Both irradiation groups show sizable decreases compared to the 
control, but the differences were not deemed statistically significant. Mean +/- SEM.  
*P < 0.05 
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Trabecular Number 
 The trabecular number (TbN) shows statistically significant differences in both the 18 
Gy and 3x6 Gy groups when compared to the control. The 18 Gy group exhibited a 12.6% 
decrease (p-value = 0.0410), while the fractionated group showed a bigger 19.6% drop (p-
value = 0.0011). The difference between the 18 Gy single dose and the 3x6 Gy fractionated 
group was not deemed statistically significant.  
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Figure 11: Trabecular number (TbN) measures the average number of trabeculae per unit 
length. Both the single acute and fractionated groups show statistically significant decrease 
compared to the control. Mean +/- SEM. *P < 0.05 
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Trabecular Thickness 
 The trabecular thickness (TbTh) results are shown below in Figure 12. There is 
minimal difference among all three groups. No statistically significant results were observed. 
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Figure 12: Trabecular Thickness (TbTh) indicates the mean thickness of trabeculae. No 
statistically significant differences were observed among all three groups.  Mean +/- SEM. 
*P < 0.05 
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Trabecular Separation 
 Trabecular separation (TbSp) results are shown below in Figure 13. Again, there are 
differences between the irradiated groups and control, and they are both statistically 
significant. The 18 Gy single dose group showed a 17.7% increase in trabecular separation 
(p-value = 0.0414). The 3x6 Gy fractioned group showed an even bigger 27.1% increase (p-
value = 0.0013). The difference between the 18 Gy and 3x6 Gy fractionated group was again 
not statistically significant.  
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Figure 13: Trabecular separation (TbSp) indicates the mean distance between trabeculae. 
Both irradiated groups show statistically significant increase in TbSp compared to the 
control, with the fractionated group showing notably more increase than the acute dose 
group. Mean +/- SEM. *P < 0.05 
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Micro-CT – Qualitative Analysis 
 Data obtained from the SCANCO µ80 micro-CT scanner were used to generate 
subject specific finite element models in Abaqus. The following figure depicts examples of 
the raw micro-CT images, showing the metaphysis region of interest from each of the three 
study groups. The visual differences in the trabecular bone between the groups are 
noticeable, with the changes in trabecular number, thickness and spacing most apparent.   
      
(a) 18 Gy acute dose         (b) 3x6 Gy fractionated 
 
   (c) non-irradiated  
Figure 14: Micro-CT images from all three groups. Note the differences in trabeculae quality. 
29 
 
The segmented trabecular bone micro-CT images from the same specimens in the 
previous figure are depicted below. Visually, there appears to be a reduction in connectivity 
and volume in both of the irradiated groups compared to the control, with the 3x6 specimen 
showed the most pronounced loss.   
 
Figure 15: Isolated trabecular struts from all three groups. Note the visual changes in 
trabecular connectivity, number and separation. 
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Finite Element Analysis – Compression Test  
Once the subject specific model was generated for each specimen in Abaqus, the 
basic compression test was performed by creating a fixed boundary condition at the most 
distal surface of each model. Figure 16 highlights the bottom plane in red.  
 
Figure 16: Side view of 18 Gy specimen 3052 under load, whole bone 
The same specimen is illustrated in figures 17-18 from different perspectives, with 
and without the trabecular struts inside the cortical shell. The color distribution throughout 
the model gives a visual interpretation of the level of load each region is experiencing. The 
legend in the top left corner shows how the stress level ranges from low (blue) to green 
(medium) to high (red). Figure 19 shows another specimen from the 3x6 Gy fractionated 
group in unloaded and loaded condition.  
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 Figure 17: Under load, 18 Gy specimen 3052, cortical only 
 
 
Figure 18: Under load, 18 Gy specimen 3052, whole bone  
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Figure 19: 3x6 Gy specimen, cortical and whole bone, with and without loading 
The mean summation of force results from the FE compression test are shown in the 
following figures. Figure 20 shows results from testing only the cortical bone, while figure 
21 shows results from testing the entire bone complex, including the trabecular bone. There 
were minimal differences and no statistically significant results across all groups.   
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Figure 20: FEA (cortical bone only). No significant differences. Mean +/- SEM. *P < 0.05 
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Figure 21: FEA (whole bone). No significant differences. Mean +/- SEM. *P < 0.05 
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Figure 22: FEA (trabecular only). Even though sizable differences were observed between 
the irradiated groups and the control, they were deemed not statistically significant. Mean +/- 
SEM. *P < 0.05 
 
 The result from trabecular only analysis is shown in figure 22. Despite the notable 
decrease between the irradiated groups and the control, with the 18 Gy group showing -
35.2% and 3x6 Gy fractionated group showing -58.4%, those differences were deemed to be 
not statistically significant. By comparing with figures 21-22, the relative contribution of 
trabecular bone can be seen at slightly less than 10% in the control group, and decreasing 
further in the irradiated groups.  In addition, the error bars seem to suggest an interesting 
trend in decreasing variance from the control to the single acute dose followed by the 
fractionated dose group.  
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Stiffness 
The stiffness values for the cortical bone and whole bone are shown in figures 23 and 
24, respectively. There were no statistically significant differences among the study groups. 
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Figure 23: Stiffness, cortical bone only. Mean +/- SEM. *P < 0.05 
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Figure 24: Stiffness, whole bone. Mean +/- SEM. *P < 0.05 
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The stiffness values for the trabecular bone showed a different trend. Both irradiated 
groups showed statistically significant loss in trabecular stiffness compared to the control. 
The 18 Gy single acute dose group showed a 20.5% loss (P=0.04), while the 3x6 Gy 
fractionated dose group exhibited a 39.3% loss (P<0.0001). Comparisons between the 18 Gy 
and 3x6 Gy fractionated groups did not show a statistically significant difference.  
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 Figure 25: Stiffness, trabecular only. Both irradiated groups showed statistically significant 
loss in trabecular stiffness compared to the control. Mean +/- SEM. *P < 0.05 
 
Structural Efficiency 
The mean structural efficiency results (stiffness divided by the bone volume) for the 
cortical bone alone and the whole bone are shown in figures 26 and 27, respectively. As with 
the basic compression test seen earlier, there were minimal differences between the groups, 
and none of the differences were statistically significant.  
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Figure 26: Structural efficiency, cortical bone only. No statistically significant differences 
were observed. Mean +/- SEM. *P < 0.05 
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Figure 27: Structural efficiency, whole bone. No statistically significant results were 
observed. Mean +/- SEM. *P < 0.05  
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 The structural efficiency result for the trabecular bone showed a different trend. The 
3x6 Gy fractionated dose group showed a statistically significant 42.5% decrease in 
structural efficiency compared to the control group (P=0.0021). The 18 Gy single acute dose 
group also showed a sizable decrease, however the difference was not deemed statistically 
significant. No statistically significant differences were observed between the two irradiated 
groups. 
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Figure 28: Structural efficiency, trabecular only. The 3x6 Gy fractionated group showed 
statistically significant 42.5% decrease compared to the control. The 18 Gy single acute dose 
group also showed a sizable decrease compared to the control, but this difference was not 
statistically significant. No significant differences were observed between the two irradiated 
groups. Mean +/- SEM. *P < 0.05 
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CHAPTER 4: DISCUSSION AND FUTURE WORK 
The results from this study indicated that although the two irradiated groups clearly 
suffered some level of bone loss, it was not as pronounced as anticipated. In addition, none of 
the results pointed to a statistically significant difference in the degree of bone loss between 
the single acute dose and fractioned group. These findings do not support our hypothesis that 
a large single acute dose would be more damaging than its fractionated counterpart.  
Body Weight 
The average mice weight data shown in figure 7 shows an expected trend. All three 
groups started with similar body mass and exhibited a decrease in the early days of the study. 
This could be attributed to stress induced by a new environment and handlers. Both irradiated 
groups showed a sharper decline in weight than the control. This was expected, as the side 
effects of radiation exposure such as nausea and fatigue may have played a role. Of note, the 
18 Gy group quickly recovered by the midpoint of the study and mirrored the control group 
from that point on, while the 3x6 Gy group did not recover as quickly or robustly. This was 
most likely due to the repeated radiation exposure and the accompanying periods of distress.   
Trabecular Microarchitectural Parameters 
The various trabecular microarchitectural parameters obtained from the micro-CT 
analysis showed a clear trend at first glance. Trabecular bone volume fraction (BV/TV), 
volumetric bone mineral density (vBMD), trabecular number (TbN) and separation (TbSp) 
all indicated statistically significant bone loss in the two irradiated groups relative to controls. 
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Similar effects of ionizing radiation on healthy bone tissues has been established in literature, 
and these findings were within expectations and comparable with previously establish works 
(Hamilton et al., 2006; Willey et al., 2011; Willey et al., 2008; Wright et al., 2015).  
There was no clear relationship between the 18 Gy single acute dose and 3x6 Gy 
fractionated group. We had hypothesized that the acute dose would be more traumatic and 
result in more pronounced bone loss compared to fractionation, and there was no statistically 
significant evidence for or against it here. However, the dataset overall does follow a general 
trend of the fractionated group consistently performing poorer than the 18 Gy group across 
the six trabecular parameters examined. For example, ConnD, while deemed not statistically 
significant, declined in both irradiated groups compared to the control, with the 3x6 Gy 
group showing roughly double the loss as the 18 Gy group. With BV/TV and vBMD, the 3x6 
Gy group consistently exhibited close to double the amount of percentage loss vs control 
when compared with the 18 Gy group. Trabecular number and separation also continued this 
trend, with the 3x6 Gy group showing at least 50% more percentage difference versus control 
when compared with the 18 Gy group. With the trabecular thickness results showing very 
little difference between the two irradiated groups, the trabecular parameters as a group 
suggest a more complicated relationship than originally anticipated between the single acute 
and fractionated dose groups.  
Finite Element Analysis 
The motivation for pursuing finite element analysis was to gain additional insight into 
the effect of the structural changes induced by radiation on bone strength. One way to 
characterize bone strength is through its stiffness, which is defined as the force divided by 
displacement produced by the force, or k=F/δ. Structural efficiency, defined as stiffness 
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divided by total bone volume, can provide an additional method of characterizing and 
quantifying the effect of changes in the bone’s overall strength.  
For the scope of this study, we assumed the bone to be isotropic in nature. The 
material properties were assigned an elastic modulus of 10 GPa and Poisson’s ratio of 0.3, 
which are the classically accepted values in this research area and experimentally verified 
(Blanchard et al., 2013; Chattah et al., 2009; Nyman et al., 2015). This allowed us to perform 
the axial compression test with our subject specific finite element models and obtain a 
preliminary understanding of the overall effect on bone strength from changes in the bone’s 
structural integrity. In doing so, we need to be mindful of the limitations imposed by this 
assumption in material property. By assigning the same material property values to both 
trabecular and cortical bone, we are assuming the entire bone to be completely homogeneous. 
As a result, our FE model is examining only the structural component and does not take into 
account any variability in material properties. At first glance, this might make our data highly 
sensitive to variations in the elastic modulus. However, since we are using a linear elastic 
model, we would not see any difference in the data as the results would all scale accordingly 
as long as there is no structural change. In addition, we can ascertain the roles played by the 
cortical and trabecular bone, and consequently their effect on overall bone strength, by 
looking at their relative strength compared to one another. Indeed, this was the motivation for 
examining our FEA models in whole bone and cortical/trabecular only configurations.  
Analysis on the trabecular only configuration revealed some interesting results. Even 
though they were deemed not statistically significant, the summation of forces results shown 
in figure 22 hinted at a decreasing trend in trabecular strength from the control to the two 
irradiated groups. In addition, the variability observed in the three study groups showed a 
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remarkable trend of decrease. The control group exhibited notable variance, but this 
variability was vastly reduced in the 18 Gy single dose group and virtually disappeared in the 
3x6 Gy fractionated dose group. The trabecular stiffness result shown in figure 25 also 
supported the trend of decreasing trabecular strength, with the 18 Gy group showing 20.5% 
loss (P=0.04) and the 3x6 fractionated group showing close to twice as much loss at 39.3% 
(P<0.0001) compared to the control. Structural efficiency results followed a similar trend, 
with the 3x6 Gy fractionated dose group showing a significant decrease of 42.5% (P=0.0021) 
compared to the control. Together, these results suggested a significant decrease in overall 
trabecular strength post radiation, with the 3x6 Gy fractionated dose group suffering notably 
greater loss than the 18 Gy single acute dose group. Furthermore, the trend of decreasing 
variability observed in the summation of forces results was very interesting. It hinted at 
trabecular bone’s radiosensitivity, suggesting that fractionation may have caused more rapid 
and uniform loss in trabecular strength.  
The FEA results for whole bone and cortical only showed no statistically significant 
differences. This lack of change in overall bone strength post radiation suggested that despite 
notable degree of trabecular bone loss from irradiation, the overall strength of the tibia was 
not significantly impacted in a negative manner. This could be clearly observed in our FEA 
mean summation of force result shown in figures 20-22. While the changes observed were 
not deemed statistically significant, the relative contribution of the trabecular bone was lower 
than 10% of the total bone strength in the control group, and even lower in the two irradiated 
groups. In other words, our FEA results seemed to suggest that trabecular microstructural 
changes do not play significant roles in the overall bone strength. This in term presented a 
potential discordance with the clinical evidence of increased prevalence of hip fracture in 
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gynecological cancer patients receiving radiotherapy. One plausible explanation is that the 
bone, being a dynamic system, is able to sufficiently compensate for the loss in trabecular 
structural strength through other means, at least in the early stages. In their 2010 study, 
Wernle et al investigated the effect of local irradiation (5 or 20 Gy) on the bone strength of 
13 week-old female Balb/c mice. By looking at time points 2, 6, 12 and 26 weeks after 
irradiation, Wernle et al found that the mice actually exhibited an increase in bone volume 
and strength at 2 weeks post irradiation. By week 12, there was a loss of bone strength 
despite the higher bone volume (Wernle et al., 2010). Their result was indicative of a 
decrease in overall structural efficiency and possibly a change in the bone material property. 
With our study, we observed significant trabecular bone loss but did not observe any 
statistically significant changes in overall structural efficiency and bone stiffness. While the 
results from the Wernle study may not be directly comparable due to the differences in study 
design (irradiation dosage, mice strain and study length), they point to the possibility that a 
similar effect of bone strength fluctuation in the early stages post irradiation may be in play 
in our study, which may have contributed to the observed FEA results. Despite some 
differences in study design, both studies point to the importance and significance of material 
property change in bone strength. It is plausible that changes in material property play a 
bigger role than structural changes in overall bone strength than previously anticipated. From 
a clinical perspective, this could help to explain the higher incidence of fracture post 
radiotherapy observed in cancer patients.    
 Another reason for the discordance between the clinical data of fracture incidence rate 
in gynecological patients and our FEA results could be the inherent limitations of our FE 
model. As pointed out earlier, we assumed the material property of the bone to be isotropic 
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and homogeneous. Consequently, we assumed the material model to be linear elastic and the 
small displacement performed in the axial compression test to be within this linear region. 
This meant our FE model was a good model throughout the linear elastic region of the bone’s 
stress-strain curve, but it provided no information about the actual failure point. This was 
sufficient for this study, as the focus was on the effect of changes in radiation-induced 
structural changes in the bone and their effect on overall bone strength. In order to get a more 
complete picture that includes information on yield point and material properties, further 
work would be required. This could be achieved experimentally with nano-indentation to 
refine the model (Blanchard et al., 2013; Nyman et al., 2015).   
In summary, structural strength characterized through stiffness and structural 
efficiency provided an incomplete picture of overall bone strength. The assumptions made 
regarding the bone’s material property limited the validity of our FE model to the linear 
elastic portion of the stress-strain curve. While micro-CT and our specimen-specific FE 
models allowed for a detailed look into changes in trabecular structure, it did not provide 
information on its material property or failure point. Even though the differences in stiffness 
and structural efficiency were all deemed statistically insignificant, together they seem to hint 
at a potentially interesting development – a compensation mechanism where the cortical bone 
somehow increases its stiffness to compensate for the loss in trabecular structural strength. 
There are many factors that affect cortical bone’s mechanical competency, including bone 
mineral density, bone mineral content, cortical thickness, cortical porosity and crystallinity 
(Augat and Schorlemmer, 2006). It is plausible that the cortical shell underwent changes in 
some or all of the above mentioned parameters as a response to losses in trabecular strength. 
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Even though it was beyond the scope of this manuscript, the effect of potential compensation 
mechanisms certainly presents a logical next target for future studies. 
Sources of Variance  
In their 2016 study, Crezee et al found that hyperthermia combined with radiotherapy 
significantly improved regional control and overall survival for cervical tumors compared to 
radiotherapy alone (Crezee et al., 2016). Of course, this clinical human study cannot be 
directly compared to our preclinical animal model. In addition, the targets in the Crezee study 
were cervical cancer cells, which have altered metabolism and radiation response compared 
to normal, healthy cells. Indeed, we must recognize that the radiation treatments used in the 
mouse are often quite different than their human counterparts (Verhaegen et al., 2011). Still, 
these findings suggest that temperature could be another factor that affects biologic tissue 
radiosensitivity.  
Another potential source of variance is the immobilization procedures used to secure 
the mice for irradiation. In general, cells with high radiosensitivity or early responding 
behaviors to radiation have a higher alpha/beta ratio than those with lower radiosensitivity 
(Douglas and Fowler, 1976; Fowler, 2010; Williams et al., 1985). In their 1993 study, Stuben 
et al examined the effect of different immobilization procedures on single dose and 
fractionated dose irradiation. They found that the effect of different immobilization 
procedures changed the alpha/beta ratio in Foster’s equation, especially when large fraction 
sizes are involved (Stuben et al., 1993). Further look into this effect of immobilization 
procedures on radiosensitivity could help reduce the amount of type I errors in the 
characterization of radiation-induced bone loss. 
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A recurring theme in our data was the presence of observed trends in some 
parameters that lacked statistically significant differences. For example, the trabecular 
parameter ConnD (connectivity density) showed a notable decrease in both irradiated groups 
compared to the control. The 18 Gy group declined 19.6%, while the 3x6 Gy group lost just 
over twice as much at 40.5% compared to the control. Both differences were not statistically 
significant. Another example would be the trend of the 3x6 Gy fractionated group 
consistently showing more negative results across the parameters when compared to the 18 
Gy single acute dose group, but without statistically significant differences. One possible 
explanation could be attributed to the innate nuisances of the trabecular parameters. For 
instance, the trabecular thickness (Tb.Th) parameter by definition was a scalar mean for the 
given region of interest (ROI). While it could be a good indicator for the overall thickness 
and health of the trabeculae, Tb.Th’s nature as an average meant that it had the potential to 
overlook some structural changes. Hypothetically, two groups can have the same Tb.Th 
values even if they contained radically different trabecular architecture. One group could 
contain trabeculae with uniform thickness, while the other could contain thick trabeculae 
interconnected by thin struts.  
Another possible reason may be attributed to the micro-CT analysis process. Once 
specimen was scanned, the cortical and trabecular sections were manually delineated through 
the creation of contours or regions of interest. This process certainly had the potential to 
introduce extra variance in the border region between the two sections. We were mindful of 
this potential source of variance and planned the study accordingly to minimize its impact. 
The same person traced all samples in the study to maintain consistency in the creation of the 
cortical and trabecular sections. Auto-contouring, used across all specimen samples, further 
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reduce potential variance by minimizing manual tracing and maximizing consistency. 
Another potential source of variance in the micro-CT analysis process was segmentation, or 
the identification of bone material in the region of interest. A threshold value for mineralized 
material was used to accept or reject a voxel as bone material, ideally including all visible 
bone while excluding all other artifacts. This is an inherently imperfect system for a couple 
of reasons. First, since newly formed osteoid has lower density than older bone, some might 
not be identified correctly depending on the age of the bone tissue. Second, it is plausible that 
there might be some variation in the rate of mineralization among individual animals, which 
might lead to additional variances across the study groups. To minimize variances from the 
segmentation process, we drew upon our research lab’s significant past experience and study 
results in choosing the optimal threshold value. In addition, the homogeneity of the mice age 
and normalization of their weight across study groups would have helped to mitigate 
variance from differences in the rate of mineralization among the animals. Finally, the 
SCANCO micro-CT scanner automatically applies a Gaussian filter on the raw image for 
noise reduction purposes. Even though it is an established process and does a good job in 
reducing noise, the filter is not perfect and will inevitably allow some noise to get through. 
The presence of this noise could potentially introduce some error in the segmentation process 
and parameter calculations.    
Even though our sample size of twelve mice per study group was reasonable and no 
animals were lost or excluded prematurely, we cannot rule out that a higher statistical power 
may have been helpful to counter the seemingly higher than expected variance (Charan and 
Kantharia, 2013). For future studies, it would be beneficial to have broader collaboration 
with additional experts in biostatistics to ensure adequate statistical power.                   
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Mouse Model Limitations 
 The choice of the C57BL/6 mouse as the animal model for this study was based on 
the similarities in skeletal system and bone remodeling process between the strain and its 
human counterpart. It has been argued that by using a single inbred strain, such as the 
C57BL/6, studies may potentially generate results that is not entirely applicable to the 
population at large since it might have been dependent upon the unique collection of genes in 
an inbred strain (Miller et al., 1999). A counterargument suggests that genetically 
heterogeneous mice represent a poor source material for controlled studies due to the 
inherent phenotypic variability and resulting decline in experimental sensitivity (Festing, 
1999). There are valid points on both sides of the aisle.  
In the context of this study, the C57BL/6 mouse strain fulfills the needs of our animal 
model with great proficiency. As with humans, C57BL/6 mice start to lose cancellous or 
trabecular bone early in adulthood (Halloran et al., 2002). Both also start to experience loss 
of bone strength before loss of BMD determined via DXA (Almeida et al., 2007; Hui et al., 
1988). The median life span of this strain is 901 days for males and 866 days for females 
(Yuan et al., 2009). This relatively long life span pushes unwanted age-related pathologies, 
metabolic disorders and illnesses further back compared to mouse strains with shorter life 
spans, thus reducing the chance of their involvement in any observed changes in bone 
structure or bone loss (Jilka, 2013).  
Of course, no animal model is completely perfect. In humans, age-related changes in 
trabecular architecture involve decreased trabecular connectivity, number and thickness, with 
a larger decrease in thickness in men than in women (Seeman, 2002). C57BL/6 mice only 
shows decline in trabecular connectivity and number but not thickness (Glatt et al., 2007). 
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Possible causes for this difference may be the much higher bone turnover rate and smaller 
scale of the mouse skeleton, where thinned trabecular bones are more transient and less likely 
to be observed (Jilka, 2013). Another notable difference between mice and humans is that 
mice do not undergo a true menopause. Instead, they exhibit irregular cycling, typically 
around 8 to 12 months of age in the case of the C57BL/6 mice (Mobbs et al., 1985). Still, the 
fact that the C57BL/6 strain is used extensively in the field of age-related bone loss and 
osteoporosis means there is a wealth of knowledge on this particular strain from previous 
studies. This adds to the robustness of the animal model as it makes it easier to compare data 
and build upon previous work.    
Future work 
 The results from this study compared well with established knowledge regarding 
basic bone loss induced by radiation compared to a non-irradiated control group. The 
relationship between single acute dose and the equivalent fractionated dose group was not as 
clear. As we mentioned before, the skeletal system is complex and dynamic. It is very 
plausible, and highly likely, that there are still many confounding factors that may not be 
obvious or sensitive to micro-CT and FEA by themselves. As we pointed out earlier, the 
primary limitation in our FEA model was the assumption made with the material properties 
of the bone. The resulting model was sufficient for the linear elastic region of the bone’s 
stress-strain curve, but it provided no information about the actual failure point. Overall bone 
strength depends not only on structural integrity but also material property as well. For 
example, Wernle et al showed in their 2010 study a decrease in bone strength despite an 
increase in bone volume post irradiation. This result strongly pointed to a causal relationship 
between loss of bone strength and changes in material properties. Therefore, the logical next 
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step from this study would be to take a deeper look at bone material property. Experimental 
tests such as micro and nano-indentation would help provide crucial material property 
information that could be used to refine our FE models. To investigate other potential 
confounding factors, examination of the bone on the cellular level would be another 
promising path, starting with incorporating histological analyses such as hematoxylin and 
eosin staining, an established method for studying morphologic changes in cells and tissues 
(Fischer et al., 2008). The various signaling pathways and biomarkers associated with the 
bone remodeling cycle would be another area of future research that could provide new 
insights. Interdisciplinary collaboration with other experts in pathology, histology and 
molecular biology should be pursued to allow for an even more comprehensive investigation 
approach.          
 Future studies may also want to explore adding more variation in radiation dosage. 
This could help reveal more information and improve upon the dose-response relationship. 
Longitudinal studies using additional techniques such as quantitative computed tomography 
could be useful in revealing more information about ionizing radiation’s long term effect on 
cell recovery and repair process, ultimately aiding in clinical treatment refinement.  
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